Invention Grant
- Patent Title: Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
-
Application No.: US13876759Application Date: 2011-09-29
-
Publication No.: US10246691B2Publication Date: 2019-04-02
- Inventor: Matthew Sweeney , Mark Wogulis
- Applicant: Matthew Sweeney , Mark Wogulis
- Applicant Address: US CA Davis
- Assignee: Novozymes, Inc.
- Current Assignee: Novozymes, Inc.
- Current Assignee Address: US CA Davis
- Agent Robert Starnes
- International Application: PCT/US2011/054034 WO 20110929
- International Announcement: WO2012/044835 WO 20120405
- Main IPC: C12N9/18
- IPC: C12N9/18 ; C12N9/42 ; D21C5/00 ; C12N15/82
Abstract:
The present invention relates to variants of GH61 polypeptides having cellulolytic enhancing activity, wherein the variants comprise a substitution at one or more positions corresponding to positions 90, 131, 134, and 141 of the full-length polypeptide of SEQ ID NO: 2, and have cellulolytic enhancing activity. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Public/Granted literature
- US20130219568A1 Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same Public/Granted day:2013-08-22
Information query
